These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3691644)

  • 1. Autoradiography of LSD and 2,5-dimethoxyphenylisopropylamine psychotomimetics demonstrates regional, specific cross-displacement in the rat brain.
    McKenna DJ; Saavedra JM
    Eur J Pharmacol; 1987 Oct; 142(2):313-5. PubMed ID: 3691644
    [No Abstract]   [Full Text] [Related]  

  • 2. LSD or DOB?
    Davis WM
    Am J Psychiatry; 1982 Dec; 139(12):1649. PubMed ID: 7149079
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].
    Otaka T
    Seishin Shinkeigaku Zasshi; 1974; 76(2):103-28. PubMed ID: 4472773
    [No Abstract]   [Full Text] [Related]  

  • 5. Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [125I]LSD and [125I]DOI, a new psychotomimetic radioligand.
    McKenna DJ; Nazarali AJ; Hoffman AJ; Nichols DE; Mathis CA; Saavedra JM
    Brain Res; 1989 Jan; 476(1):45-56. PubMed ID: 2536576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
    Sanders-Bush E; Burris KD; Knoth K
    J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
    Pierce PA; Peroutka SJ
    J Pharmacol Exp Ther; 1988 Dec; 247(3):918-25. PubMed ID: 3204523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural correlation between apomorphine and LSD: involvement of dopamine as well as serotonin in the actions of hallucinogens.
    Nichols DE
    J Theor Biol; 1976 Jun; 59(1):167-77. PubMed ID: 7711
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct quantitative analysis of lysergic acid diethylamide (LSD) and 2, 5-dimethoxy-4-methylamphetamine (STP) on thin-layer chromatograms.
    Niwaguchi T; Inoue T
    J Chromatogr; 1976 Jun; 121(1):165-9. PubMed ID: 932131
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites.
    Buchborn T; Schröder H; Dieterich DC; Grecksch G; Höllt V
    Behav Brain Res; 2015 Mar; 281():62-8. PubMed ID: 25513973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
    Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA
    Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR studies on psychotomimetic phenylalkylamines.
    Gupta SP; Handa A; Bindal MC; Singh P
    Arzneimittelforschung; 1983; 33(8):1089-90. PubMed ID: 6685483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive method for determining levels of [-]-2,5,-dimethoxy-4-methylamphetamine in the brain tissue.
    Eckler JR; Greizerstein H; Rabin RA; Winter JC
    J Pharmacol Toxicol Methods; 2001; 46(1):37-43. PubMed ID: 12164258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex.
    Muschamp JW; Regina MJ; Hull EM; Winter JC; Rabin RA
    Brain Res; 2004 Oct; 1023(1):134-40. PubMed ID: 15364028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.
    Dolder PC; Schmid Y; Steuer AE; Kraemer T; Rentsch KM; Hammann F; Liechti ME
    Clin Pharmacokinet; 2017 Oct; 56(10):1219-1230. PubMed ID: 28197931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
    Morin RD; Benington F; Mitchell SR; Beaton JM; Bradley RJ; Smythies JR
    Experientia; 1975 Jan; 31(1):93-5. PubMed ID: 234850
    [No Abstract]   [Full Text] [Related]  

  • 18. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ; Commissaris RL; Warner MR; Rech RH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R(-)-2,5-dimethoxy-4-77 bromoamphetamine [77Br-R(-)DOB]: a novel radioligand which labels a 5-HT binding site subtype.
    Wang SS; Mathis CA; Peroutka SJ
    Psychopharmacology (Berl); 1988; 94(3):431-2. PubMed ID: 3357926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 2,5-dimethoxy-4-methylamphetamine on the behavior of rats in competition for food.
    Uyeno ET
    Int Pharmacopsychiatry; 1972; 7(1-4):244-8. PubMed ID: 4681210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.